Literature DB >> 20952741

Metabolite formation of 17alpha-hydroxyprogesterone as a consequence of e⁻(aq)-emission and progesterone effect regarding cancer.

Nikola Getoff1, Iren Danielova, Johannes Hartmann, Heike Schittl, Marion Gerschpacher, Shaobin Ying, Ruth Quint, Johannes C Huber.   

Abstract

Based on previous investigations on several hormones, 17α-hydroxyprogesterone (17α-HOPRG) was studied in respect to cancer initiation by its metabolites resulting from electron emission. The emission of electrons (e⁻(aq)) from its singlet excited state of 17α-HOPRG and HPLC-analysis of products were studied. Possible carcinogenicity of metabolites originating from 17α-HOPRG and the effect of progesterone (PRG) in this respect were studied in vitro. The results showed that 17α-HOPRG is very sensitive towards oxygen. The highest Q(e⁻(aq)) values were obtained by dissolution and UV-irradiation of substrate in airfree media. 17α-HOPRG metabolites showed a strong anticancer activity, which is, however, lower compared to that of PRG-metabolites. Mixture of both hormones, 17α-HOPRG and PRG, in respect to carcinogenicity showed a synergistic effect of PRG on 17α-HOPRG. Reaction mechanisms are presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952741

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

1.  Electron emission and product analysis of estrone: progesterone interactions studied by experiments in vitro.

Authors:  Marion Gerschpacher; Nikola Getoff; Johannes Hartmann; Heike Schittl; Iren Danielova; Shaobin Ying; Johannes C Huber; Ruth M Quint
Journal:  Gynecol Endocrinol       Date:  2010-06-29       Impact factor: 2.260

2.  Photo-induced regeneration of hormones by electron transfer processes: Potential biological and medical consequences.

Authors:  Nikola Getoff; Johannes Hartmann; Heike Schittl; Marion Gerschpacher; Ruth Maria Quint
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2011-08       Impact factor: 2.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.